![Daniel Sindelar](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Daniel Sindelar first degree
Entity | Entity type | Industry | |
---|---|---|---|
Keystone Bio, Inc.
![]() Keystone Bio, Inc. BiotechnologyHealth Technology Keystone Bio, Inc. engages in operation PharmaBiome biotech company. It develops pathogen of chronic inflammation that is shown to initiate and advance Atherosclerosis, heart disease, and Alzheimer's disease. The company is headquartered in St. Louis, MO.
2
| Private Company | Biotechnology | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Daniel Sindelar via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Oakwood Medical Investors
![]() Oakwood Medical Investors Investment ManagersFinance Oakwood Medical Investors (Oakwood Medical Investors) is a venture capital firm founded in 1997 by Raul Perez. The firm is headquartered in Louis, Missouri. | Investment Managers | Private Equity Investor | |
PrognostiX, Inc.
![]() PrognostiX, Inc. Pharmaceuticals: MajorHealth Technology PrognostiX, Inc. discovers and develops biomarker technologies. The firm also offers cardiovascular and inflammatory biomarkers. The company was founded in 2004 and is headquartered in Cleveland, OH. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Cleveland HeartLab, Inc.
![]() Cleveland HeartLab, Inc. Medical/Nursing ServicesHealth Services Cleveland HeartLab, Inc. operates as a holding and clinical reference laboratory company. It focuses on novel molecular biomarker technologies and the creation of proprietary diagnostic tests. The company was founded by Jake Orville and Marc S. Penn in 2009 and is headquartered in Cleveland, OH. | Medical/Nursing Services | Founder | |
Juventas Therapeutics, Inc.
![]() Juventas Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Juventas Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. It is a clinical-stage biotechnology company developing a pipeline of factor-based regenerative therapies to treat life-threatening diseases. The company's product has been shown to protect and repair tissue following ischemic injury by recruiting the body's own stem cells to the damaged tissue. The company was founded by Rahul A. Aras and Marc S. Penn in 2007 and is headquartered in Cleveland, OH. | Hospital/Nursing Management | Founder | |
Case Western Reserve University
![]() Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Graduate Degree | |
Summa Health System (Ohio)
![]() Summa Health System (Ohio) Hospital/Nursing ManagementHealth Services Summa Health System, Inc. provides integrated and coordinated care services. It offers medical, specialized, support, and testing services. The company was founded in 1989 and is headquartered in Akron, OH. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
Northeast Ohio Medical University | College/University | Corporate Officer/Principal | |
Kenwood Health Group | Chief Tech/Sci/R&D Officer | ||
SnappSkin, Inc. | Miscellaneous | Director/Board Member | |
Rhythm Therapeutics, Inc. | Biotechnology | Director/Board Member | |
Diasome Pharmaceuticals, Inc.
![]() Diasome Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diasome Pharmaceuticals, Inc. operates as a clinical stage diabetes therapeutics company which designs and develops insulin-based therapies for the treatment of diabetes. It focuses on the clinical and commercial development of breakthrough therapies for diabetes and obesity. The company’s technology platform is based on the use of its proprietary Hepatocyte Directed Vesicle or HDV, nanotechnology to deliver a wide range of critically necessary hormones and drugs to the liver, the body’s primary site of glucose storage. The firm’s HDV system is designed to fundamentally improve the way in which insulin works in people with diabetes by enabling much greater amounts of injected insulin to reach hepatocytes, the liver’s glucose storing cells. The company was founded by Len Rosenberg, Lance Converse, W. Blair Geho and Robert Geho in 2004 and is headquartered in Cleveland, OH. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
LANTERN PHARMA INC. | Pharmaceuticals: Major | Founder | |
Biological Mimetics, Inc.
![]() Biological Mimetics, Inc. Pharmaceuticals: MajorHealth Technology Biological Mimetics, Inc. engages in the provision of pharmaceutical products. It offers deceptive imprinting, vaccines, dampening, refocusing, and therapeutic antibodies. The company was founded by Peter L. Nara in 1996 and is headquartered in Frederick, MD. | Pharmaceuticals: Major | Founder |
Statistics
International
United States | 17 |
Sectoral
Health Technology | 6 |
Health Services | 5 |
Finance | 3 |
Consumer Services | 3 |
Miscellaneous | 2 |
Operational
Chief Tech/Sci/R&D Officer | 8 |
Director/Board Member | 8 |
Founder | 5 |
Private Equity Investor | 2 |
Corporate Officer/Principal | 2 |
Most connected contacts
Insiders | |
---|---|
Marc Penn | 15 |
Peter L. Nara | 3 |
- Stock Market
- Insiders
- Daniel Sindelar
- Company connections